rajni kannan discusses managing aes from combination therapies in melanoma
Published 8 years ago • 47 plays • Length 1:40Download video MP4
Download video MP3
Similar videos
-
0:56
rajni kannan on risk factors for melanoma
-
1:41
kathleen m. madden on managing aes from targeted therapies for melanoma
-
0:55
rajni kannan on managing the side effects of ipilimumab and vemurafenib
-
1:10
rajni kannan on the nurse’s role in skin cancer prevention outreach
-
1:52
rajni kannan on discussing clinical trials with cancer patients
-
20:55
what is stage iv melanoma?
-
4:00
valerie's story: valerie shares how she beat her malignant melanoma
-
24:26
melanoma: advancement in treatment 2021
-
1:40
using steroids to manage immunotherapy-associated aes in melanoma
-
7:26
immunotherapy in melanoma: managing toxicities
-
5:46
combination therapies for melanoma
-
2:06
kathleen m. madden provides an overview of targeted therapies for melanoma patients
-
1:14
dr. johnson on promise of combination therapy in melanoma
-
4:15
stage iv melanoma cancer treatment options explained: immunotherapy and targeted therapy
-
7:48
immunotherapy combinations in advanced melanoma
-
9:49
melanoma: nuances of braf/mek combinations in the front line
-
4:12
melanoma research alliance presents: the promise of immunotherapy
-
5:40
managing brain metastases and side effects in melanoma
-
3:10
the future of immunotherapy in melanoma
-
17:37
managing adverse effects with immunotherapy
-
10:42
what is new in melanoma?
-
7:51
checkpoint inhibitors: combination therapy in melanoma